Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Colorectal Neoplasms

  Free Subscription


1 Ann Surg Oncol
4 BMC Cancer
1 BMC Gastroenterol
3 Br J Cancer
1 Cancer Lett
1 Curr Treat Options Oncol
1 Dis Colon Rectum
2 Eur J Surg Oncol
1 Gut
6 Int J Cancer
9 Int J Colorectal Dis
2 J Clin Oncol
1 J Pathol
2 J Surg Oncol
2 Lancet Oncol
2 N Engl J Med
6 PLoS One
2 World J Surg

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Ann Surg Oncol

  1. THEISS LM, Lucy AT, Bergstresser SL, Chu DI, et al
    Disparities in Surgical Timing and Guideline-Adherent Staging Work-Up for Colon Cancer.
    Ann Surg Oncol. 2022 Jun 6. pii: 10.1245/s10434-022-11938.
    PubMed         Abstract available

    BMC Cancer

  2. SZIGETI KA, Kalmar A, Galamb O, Valcz G, et al
    Global DNA hypomethylation of colorectal tumours detected in tissue and liquid biopsies may be related to decreased methyl-donor content.
    BMC Cancer. 2022;22:605.
    PubMed         Abstract available

  3. AL-MTERIN MA, Murshed K, Alsalman A, Abu-Dayeh A, et al
    Associations of different immune checkpoints-expressing CD4(+) Treg/ T cell subsets with disease-free survival in colorectal cancer patients.
    BMC Cancer. 2022;22:601.
    PubMed         Abstract available

  4. THEOPHANOUS S, Samuel R, Lilley J, Henry A, et al
    Prognostic factors for patients with anal cancer treated with conformal radiotherapy-a systematic review.
    BMC Cancer. 2022;22:607.
    PubMed         Abstract available

  5. SU W, Feng B, Hu L, Guo X, et al
    MUC3A promotes the progression of colorectal cancer through the PI3K/Akt/mTOR pathway.
    BMC Cancer. 2022;22:602.
    PubMed         Abstract available

    BMC Gastroenterol

  6. SHI H, Wang C, Wu J, Qin B, et al
    Underwater endoscopic mucosal resection for rectal neuroendocrine tumors (with videos): a single center retrospective study.
    BMC Gastroenterol. 2022;22:276.
    PubMed         Abstract available

    Br J Cancer

  7. MORETTO R, Elliott A, Rossini D, Intini R, et al
    Benefit from upfront FOLFOXIRI and bevacizumab in BRAFV600E-mutated metastatic colorectal cancer patients: does primary tumour location matter?
    Br J Cancer. 2022 Jun 3. pii: 10.1038/s41416-022-01852.
    PubMed         Abstract available

  8. LI H, van der Merwe PA, Sivakumar S
    Biomarkers of response to PD-1 pathway blockade.
    Br J Cancer. 2022;126:1663-1675.
    PubMed         Abstract available

  9. LI Z, Wang K, Shivappa N, Hebert JR, et al
    Inflammatory potential of diet and colorectal carcinogenesis: a prospective longitudinal cohort.
    Br J Cancer. 2022;126:1735-1743.
    PubMed         Abstract available

    Cancer Lett

  10. WALTERSKIRCHEN N, Muller C, Ramos C, Zeindl S, et al
    Metastatic colorectal carcinoma-associated fibroblasts have immunosuppressive properties related to increased IGFBP2 expression.
    Cancer Lett. 2022;540:215737.
    PubMed         Abstract available

    Curr Treat Options Oncol

  11. LIU G, Zhang S, Zhang Y, Fu X, et al
    Robotic Surgery in Rectal Cancer: Potential, Challenges, and Opportunities.
    Curr Treat Options Oncol. 2022;23:961-979.
    PubMed         Abstract available

    Dis Colon Rectum

  12. HAN JG, Wang ZJ, Dai Y, Li XR, et al
    Short-term Outcomes of Elective Surgery Following Self-Expandable Metallic Stent and Neoadjuvant Chemotherapy in Patients With Left-Sided Colon Cancer Obstruction.
    Dis Colon Rectum. 2022 May 30. pii: 00003453-990000000-00065.
    PubMed         Abstract available

    Eur J Surg Oncol

  13. STURESSON C, Engstrand J, Stromberg C
    Reply to: The cohort data in the full pulmonary Metastasectomy in colorectal cancer study: Comment on Engstrand et al.
    Eur J Surg Oncol. 2022 May 27. pii: S0748-7983(22)00471.

  14. SCHUURMAN MS, Elferink MAG, Verhoef C, de Hingh IHJT, et al
    Peritoneal metastases in elderly patients with colorectal cancer.
    Eur J Surg Oncol. 2022 May 18. pii: S0748-7983(22)00438.
    PubMed         Abstract available


  15. KRYKLYVA V, Luchini C, Stommel MWJ, Nagtegaal ID, et al
    Detecting Lynch syndrome in pancreatic ductal adenocarcinoma FNA cytology based on cancer history and immunocytochemistry.
    Gut. 2021 Oct 19. pii: gutjnl-2021-326033. doi: 10.1136/gutjnl-2021-326033.

    Int J Cancer

  16. BAMBERG LV, Heigwer F, Wandmacher AM, Singh A, et al
    Targeting euchromatic histone lysine methyltransferases sensitizes colorectal cancer to histone deacetylase inhibitors.
    Int J Cancer. 2022 Jun 6. doi: 10.1002/ijc.34155.
    PubMed         Abstract available

  17. VAN ROOIJEN KL, Derksen JWG, Verkooijen HM, Vink GR, et al
    Translation of IDEA trial results into clinical practice: analysis of the implementation of a new guideline for colon cancer.
    Int J Cancer. 2022 Jun 3. doi: 10.1002/ijc.34149.
    PubMed         Abstract available

  18. ELMAHDI R, Wennerstrom ECM, Andersson M, Wohlfahrt J, et al
    Shared Environment and Colorectal Cancer: A Nordic Pedigree Registry-based Cohort Study.
    Int J Cancer. 2022 Jun 3. doi: 10.1002/ijc.34148.
    PubMed         Abstract available

  19. MARTINI G, Ciardiello D, Dallio M, Famiglietti V, et al
    Gut microbiota correlates with antitumor activity in patients with mCRC and NSCLC treated with cetuximab plus avelumab.
    Int J Cancer. 2022;151:473-480.
    PubMed         Abstract available

  20. HARLID S, Van Guelpen B, Qu C, Gylling B, et al
    Diabetes mellitus in relation to colorectal tumor molecular subtypes: A pooled analysis of more than 9000 cases.
    Int J Cancer. 2022;151:348-360.
    PubMed         Abstract available

  21. RAIMONDI A, Randon G, Prisciandaro M, Pagani F, et al
    Early onset metastatic colorectal cancer in patients receiving panitumumab-based upfront strategy: overall and sex-specific outcomes in the Valentino trial.
    Int J Cancer. 2022 Jun 9. doi: 10.1002/ijc.34156.
    PubMed         Abstract available

    Int J Colorectal Dis

  22. ZHANG XY, Liu XZ, Li XT, Wang L, et al
    MRI measurements predict major low anterior resection syndrome in rectal cancer patients.
    Int J Colorectal Dis. 2022;37:1239-1249.
    PubMed         Abstract available

  23. WEI MT, Louie CY, Chen Y, Pan JY, et al
    Randomized controlled trial investigating use of submucosal injection of EverLift in rates of complete resection of non-pedunculated 4-9 mm polyps.
    Int J Colorectal Dis. 2022;37:1273-1279.
    PubMed         Abstract available

  24. KIM JC, Park SH, Kim J, Kim CW, et al
    Involvement of tissue changes induced by neoadjuvant treatment in total mesorectal excision (TME): novel suggestions for determining TME quality.
    Int J Colorectal Dis. 2022;37:1289-1300.
    PubMed         Abstract available

  25. DAMGAARD ERIKSEN J, Emmertsen KJ, Madsen AH, Erichsen R, et al
    The impact of multiple firings on the risk of anastomotic leakage after minimally invasive restorative rectal cancer resection and the impact of anastomotic leakage on long-term survival: a population-based study.
    Int J Colorectal Dis. 2022;37:1335-1348.
    PubMed         Abstract available

  26. LUX TJ, Banck M, Sassmannshausen Z, Troya J, et al
    Pilot study of a new freely available computer-aided polyp detection system in clinical practice.
    Int J Colorectal Dis. 2022;37:1349-1354.
    PubMed         Abstract available

  27. KOHL VKB, Weber K, Brunner M, Geppert CI, et al
    Factors influencing downstaging after neoadjuvant long-course chemoradiotherapy in rectal carcinoma.
    Int J Colorectal Dis. 2022;37:1355-1365.
    PubMed         Abstract available

  28. YASUI H, Takeno A, Hara H, Imamura H, et al
    Prospective analysis of the expression status of FGFR2 and HER2 in colorectal and gastric cancer populations: DS-Screen Study.
    Int J Colorectal Dis. 2022;37:1393-1402.
    PubMed         Abstract available

  29. LALL V, Ismail AGM, Ayonrinde OT
    Disparate age and sex distribution of sessile serrated lesions and conventional adenomas in an outpatient colonoscopy population-implications for colorectal cancer screening?
    Int J Colorectal Dis. 2022 Jun 4. pii: 10.1007/s00384-022-04191.
    PubMed         Abstract available

  30. FUKUI Y, Hida K, Hoshino N, Nishizaki D, et al
    Identification of high-risk stage I colon and rectal cancer patients: a retrospective analysis of a large Japanese cohort.
    Int J Colorectal Dis. 2022;37:1403-1410.
    PubMed         Abstract available

    J Clin Oncol

  31. ROSSINI D, Antoniotti C, Lonardi S, Pietrantonio F, et al
    Upfront Modified Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan Plus Panitumumab Versus Fluorouracil, Leucovorin, and Oxaliplatin Plus Panitumumab for Patients With RAS/BRAF Wild-Type Metastatic Colorectal Cancer: The Phase III TRIPLETE Study b
    J Clin Oncol. 2022 Jun 6:JCO2200839. doi: 10.1200/JCO.22.00839.
    PubMed         Abstract available

  32. SUTCUOGLU O, Ulas Kahya B, Ozdemir N, Yazici O, et al
    Can Systemic Control Be Achieved in the Treatment of Oligometastatic Hepatocellular Cancer With Hepatic Artery Infusion Fluorouracil, Leucovorin, and Oxaliplatin Treatment?
    J Clin Oncol. 2022 Mar 29:JCO2200047. doi: 10.1200/JCO.22.00047.

    J Pathol

  33. GLAIRE MA, Ryan NA, Ijsselsteijn ME, Kedzierska K, et al
    Discordant prognosis of mismatch repair deficiency in colorectal and endometrial cancer reflects variation in antitumour immune response and immune escape.
    J Pathol. 2022;257:340-351.
    PubMed         Abstract available

    J Surg Oncol

  34. JIN L, Hu Q, Sun Y
    Association between enrollment in an enhanced recovery program for colorectal cancer surgery and long-term recurrence and survival.
    J Surg Oncol. 2022 Jun 7. doi: 10.1002/jso.26886.

  35. MO TW, Zhang ZJ, Chen YL, Huang JH, et al
    Risk factors for metachronous peritoneal carcinomatosis after radical resection for patients with nonmetastatic pT3-4 colon cancer.
    J Surg Oncol. 2022 Jun 4. doi: 10.1002/jso.26975.
    PubMed         Abstract available

    Lancet Oncol

  36. HUPKENS BJP, Breukink SO
    Personalised care for high-risk rectal cancer: does one size fit all?
    Lancet Oncol. 2022;23:697-698.

  37. LORD AC, Corr A, Chandramohan A, Hodges N, et al
    Assessment of the 2020 NICE criteria for preoperative radiotherapy in patients with rectal cancer treated by surgery alone in comparison with proven MRI prognostic factors: a retrospective cohort study.
    Lancet Oncol. 2022;23:793-801.
    PubMed         Abstract available

    N Engl J Med

  38. MONTAGUT C, Vidal J
    Liquid Biopsy for Precision Adjuvant Chemotherapy in Colon Cancer.
    N Engl J Med. 2022 Jun 4. doi: 10.1056/NEJMe2204625.

  39. TIE J, Cohen JD, Lahouel K, Lo SN, et al
    Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer.
    N Engl J Med. 2022 Jun 4. doi: 10.1056/NEJMoa2200075.
    PubMed         Abstract available

    PLoS One

  40. SOMUNCU B, Ekmekcioglu A, Antmen FM, Ertuzun T, et al
    Targeting mitochondrial DNA polymerase gamma for selective inhibition of MLH1 deficient colon cancer growth.
    PLoS One. 2022;17:e0268391.
    PubMed         Abstract available

  41. TYAGI A, Shabbir U, Chen X, Chelliah R, et al
    Phytochemical profiling and cellular antioxidant efficacy of different rice varieties in colorectal adenocarcinoma cells exposed to oxidative stress.
    PLoS One. 2022;17:e0269403.
    PubMed         Abstract available

  42. LARABEE SM, Cheng K, Raufman JP, Hu S, et al
    Muscarinic receptor activation in colon cancer selectively augments pro-proliferative microRNA-21, microRNA-221 and microRNA-222 expression.
    PLoS One. 2022;17:e0269618.
    PubMed         Abstract available

  43. MARTINEZ-LAGO N, Cameselle Garcia S, Alonso de Castro B, Gomez-Randulfe Rodriguez MI, et al
    Efficacy and safety of FOLFIRI/aflibercept (FA) in an elderly population with metastatic colorectal cancer (mCRC) after failure of an oxaliplatin-based regimen.
    PLoS One. 2022;17:e0269399.
    PubMed         Abstract available

  44. AITCHISON A, Pearson JF, Purcell RV, Frizelle FA, et al
    Detection of Fusobacterium nucleatum DNA in primary care patient stool samples does not predict progression of colorectal neoplasia.
    PLoS One. 2022;17:e0269541.
    PubMed         Abstract available

  45. LU F, Chen S, Shi W, Su X, et al
    GPC1 promotes the growth and migration of colorectal cancer cells through regulating the TGF-beta1/SMAD2 signaling pathway.
    PLoS One. 2022;17:e0269094.
    PubMed         Abstract available

    World J Surg

  46. BORAKATI A, Froghi F, Shetye A, Fusai GK, et al
    Assessing the Impact of Primary Tumour Location on Survival After Resection of Colorectal Liver Metastases: A Propensity Weighted Retrospective Cohort Study.
    World J Surg. 2022;46:1734-1755.
    PubMed         Abstract available

  47. MAO D, Rey-Conde T, North JB, Lancashire RP, et al
    Critical Analysis of the Causes of In-Hospital Mortality following Colorectal Resection: A Queensland Audit of Surgical Mortality (QASM) Registry Study.
    World J Surg. 2022;46:1796-1804.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.